Mindfulness and Bodily Distress.
Mindfulness and bodily distress.
Filed under: Depression Treatment
Dan Med J. 2012 Nov; 59(11): B4547
Fjorback LO
We have created a mindfulness approach to treat patients who experience multiple, persistent, and disabling physical symptoms that cannot be explained by a well-defined medical or surgical condition. Randomized controlled trials in this area are few, and research is hampered by the lack of clear definitions. Bodily distress syndrome (BDS) or bodily stress is an empirically defined definition unifying various conditions such as fibromyalgia, chronic fatigue syndrome, and somatization disorder. In the present PhD, we explored whether patients suffering from BDS may be committed to mental training in the form of mindfulness therapy, which is a mindfulness program specifically targeted patients suffering from BDS. The theoretical model for including mindfulness training in the treatment of BDS is based on identified neurobiological impairments in these patients and the neurobiological improvements that mindfulness training may offer. BDS is a major public health issue possibly associated with the pathology of the immuno-endocrine and autonomic nervous system. BDS patients are often stigmatized, and effective treatment is rarely delivered, which leaves these patients isolated, left by themselves, vulnerable to potentially harming medical and/or alternative treatments. Accordingly, there is a need for non-harming practical tools that patients can learn to master so that they can improve the ability to take responsibility for their own health and wellbeing. Mindfulness-Based Stress Reduction (MBSR) is a group program that employs mindfulness practice to alleviate suffering associated with physical, psychosomatic, and psychiatric disorders. Mindfulness-Based Cognitive Therapy (MBCT) is designed to prevent depressive relapse. Paper I and II present systematic literature reviews only of randomized controlled trials on MBSR and MBCT. The effect of MBSR has been explored on fibromyalgia in three studies, none of them showed convincing results, but gave some indications as to improvement. The reviews recommended MBSR as a useful method for improving mental health; however, lack of long-term follow-up and active control groups are limitations in most studies. MBCT was recommended as a tool for preventing depressive relapse in recovered, recurrently depressed patients, but the implication of MBSR and MBCT is problematic, especially due to the lack of well educated mindfulness teachers. We combined MBSR with cognitive behavioral therapy, CBT, specifically targeted BDS. Paper III provides original data from 119 patients enrolled in a randomized clinical trial, mindfulness therapy for BDS. The randomized controlled trial indicates that BDS patients are capable of and willing to engage in mindfulness therapy. This thesis showed that mindfulness therapy can safely and successfully engage BDS patients in mindfulness practice. Since individual CBT and psychiatric consultation have previously been found to have positive outcomes for BDS patients, we compared mindfulness therapy to an active control group entitled specialized treatment in which an individual treatment was planned in collaboration between the patient and an MD specialized in BDS, CBT, and psychiatry. Mindfulness therapy was comparable to specialized treatment in improving the quality of life and the symptoms of the patients with BDS at 15-month follow-up. For primary outcome physical health (PCS) at 15-month follow-up, different developments over time for the two treatment groups could not be established (F(3,2674) = 1.51, p = 0.21). However, in the mindfulness therapy group, PCS significant changed at the end of treatment and this change remained at 15-month follow-up, whereas no significantly change was seen in the specialized treatment group until at the 15-month follow-up. In the mindfulness therapy group, 26%; CI: 14-38 reported a marked improvement (> 1 SD) at the end of treatment compared with 10%; CI: 2-18 in the specialized treatment group. This amounts to a statistically… Continue reading
Hospital Discharge on the First Compared With the Second Day After a Planned Cesarean Delivery: A Randomized Controlled Trial.
Hospital discharge on the first compared with the second day after a planned cesarean delivery: a randomized controlled trial.
Filed under: Depression Treatment
Obstet Gynecol. 2012 Dec; 120(6): 1273-82
Chiong Tan P, Jin Norazilah M, Zawiah Omar S
Hospital Discharge on the First Compared With the Second Day After a Planned Cesarean Delivery: A Randomized Controlled Trial.
Hospital discharge on the first compared with the second day after a planned cesarean delivery: a randomized controlled trial.
Filed under: Depression Treatment
Obstet Gynecol. 2012 Dec; 120(6): 1273-82
Chiong Tan P, Jin Norazilah M, Zawiah Omar S
Effect of Citicoline on Functional and Cognitive Status Among Patients With Traumatic Brain Injury: Citicoline Brain Injury Treatment Trial (COBRIT).
Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
Filed under: Rehab Centers
JAMA. 2012 Nov 21; 308(19): 1993-2000
Zafonte RD, Bagiella E, Ansel BM, Novack TA, Friedewald… Continue reading
A Masterclass to Teach Public Health Professionals to Conduct Practice-Based Research to Promote Evidence-Based Practice: A Case Study From the Netherlands.
A masterclass to teach public health professionals to conduct practice-based research to promote evidence-based practice: a case study from the Netherlands.
Filed under: Rehab Centers
J Public Health Manag Pract. 2013 Jan; 19(1): 83-92
Jansen MW, Hoeijmakers M
Addiction Rehab: Chronic Escalating Cocaine Exposure, Abstinence/withdrawal, and Chronic Re-Exposure: Effects on Striatal Dopamine and Opioid Systems in C57BL/6J Mice.
Chronic escalating cocaine exposure, abstinence/withdrawal, and chronic re-exposure: Effects on striatal dopamine and opioid systems in C57BL/6J mice.
Filed under: Addiction Rehab
Neuropharmacology. 2012 Nov 16;
Zhang Y, Schlussman SD, Rabkin J, Butelman ER, Ho A, Kreek MJ
Cocaine… Continue reading